Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Analgesics in

Analgesics in Norway

Nov 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen

The outbreak of COVID-19 in 2020 is not set to drastically change growth in analgesics, with predicted growth for the year aligning to that seen in 2019. However, changes in consumer purchasing habits did take place as a consequence of the outbreak.

Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020

From 1 July 2020, the systemic analgesics diclofenac switched from being an OTC good to an Rx medication. This was due to the release of a Danish study, that revealed cardiovascular risks involved with taking the drug.

Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position

Due to the outbreak of COVID-19, Paracet has seen a steep increase in sales in 2020 and is expected to increase its market share, while also recording double-digit value growth. In contrast, all ibuprofen brands, including Ibux and Ibumentin, have seen a decline in sales due to negative press surrounding adverse effects of the drug, on patients suffering from COVID-19.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Norway market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in Norway?
What are the major brands in Norway?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in Norway - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen

Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020

Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position

RECOVERY AND OPPORTUNITIES

The forecast period will record a solid performance, as topical analgesics/anaesthetic and ibuprofen drive value growth

The outbreak of COVID-19, increases the interest in health, boosting sales for topical analgesics/anaesthetic

Prescription analgesics and a lack of innovation on the landscape are both threats to growth across the forecast period

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

Consumer Health in Norway - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2019-2020

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Analgesics in Norway

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen

Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020

Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in Norway - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen

Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020

Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position

RECOVERY AND OPPORTUNITIES

The forecast period will record a solid performance, as topical analgesics/anaesthetic and ibuprofen drive value growth

The outbreak of COVID-19, increases the interest in health, boosting sales for topical analgesics/anaesthetic

Prescription analgesics and a lack of innovation on the landscape are both threats to growth across the forecast period

CATEGORY DATA

Consumer Health in Norway - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports